YFYoshitaka Fujii

Yoshitaka Fujii

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yoshitaka Fujii has a total of 917 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Aggressive Local Therapy for Oligometastatic Non-Small Cell Lung Cancer with Resistance to Anti-Cancer Agents: a Case Report

    by Yoshitaka Fujii, Tatsuya Nishida, Kenji Nagata, Kenichi Minami, Naoki Yoshimoto, Eriko Tani, Tomonori Hirashima

    背景.IVB期肺癌であっても転移巣が限られている場合(いわゆるOligometastatic disease),局所治療を行うことで予後の改善が得られることがある.症例.50歳代男性,小腸・左副腎転移を伴うIVB期肺癌に対し,転移巣切除と3年半に及ぶ9th lineの薬物療法を行ったが,肺原発巣のみが増大した.他に病変を認めなかったため手術による完全切除可能なOligometastatic diseaseと判断し,初回の手術を行った.術後6ヶ月で右胸壁と左鎖骨下リンパ節に再発を認めたが,病変は2ヶ所のみであったためOligometastatic diseaseの再発と診断し,右胸壁の病変に対しては2回目の外科切除,左鎖骨下リンパ節の病変に対しては放射線治療を行い,その後18ヶ月は再発を認めていない.IVB期肺癌診断時から5年半の長期生存を得ており,現在は職場復帰している.結論.IVB期肺癌であっても,Oligometastatic diseaseに対する積極的な局所治療は有効であると考える.

  • Open Access

    Laser‐assisted hatching on clinical and neonatal outcomes in patients undergoing single vitrified Blastocyst transfer: A propensity score–matched study

    by Yuji Endo, Shingo Mitsuhata, Momoko Hayashi, Yoshitaka Fujii, Hiroaki Motoyama

    Purpose: This study determined the effect of laser‐assisted hatching on the clinical and neonatal outcomes of single vitrified blastocyst transfer.Methods: From June 2014 to March 2018, 289 matched pairs after propensity score matching were analyzed. During the blastocyst warming procedure, a small section of the zona pellucida area in the empty perivitelline space was sliced off using multiple laser beams. The clinical and neonatal outcomes of the laser‐treated group and non‐treatment control were analyzed.Results: In the laser‐assisted hatching group, significantly higher rates of clinical pregnancy (40.8% vs 29.4%, P < .01) and live delivery (34.3% vs 22.5%, P < .01) were observed compared to the control group. Other variables such as the average gestational weeks, the sex of the baby, birthweight, or congenital malformations were found to have no significant differences in neonatal outcomes. Moreover, all babies were singleton live births.Conclusions: Single vitrified blastocyst transfer treated with laser‐assisted hatching increases the live birth rate and has no adverse effects on neonatal outcomes.


  • Open Access

    Effect of equilibration time on clinical and neonatal outcomes in human blastocysts vitrification

    by Shingo Mitsuhata, Momoko Hayashi, Yoshitaka Fujii, Hiroaki Motoyama, Yuji Endo

    Purpose: Prolonged exposure to equilibration solutions may be detrimental to an embryo's developmental potential, whereas a shorter exposure may affect the penetration of cryoprotectants into blastomeres. The purpose of this study was to evaluate the effects of different equilibration times on the clinical and neonatal outcomes of human blastocyst vitrification.Methods: This is a retrospective study based on data collected between November 2008 and November 2015. A total of 192 blastocysts (80 non‐expanded and 112 expanded) obtained from 167 patients were analyzed. The blastocysts were divided into two groups according to their equilibration time: 8‐11 minutes or 12‐15 minutes. The clinical and neonatal outcomes of warmed blastocysts were evaluated.Results: The survival, implantation, and live birth rates of non‐expanded blastocysts were not different between the two groups, but they significantly improved for the expanded blastocysts in the 12‐15 minutes group compared to the 8‐11 minutes group. The results were similar for the neonatal outcomes after vitrified embryo transfer, when partitioned by equilibration time and blastocyst stage at vitrification.Conclusions: For the non‐expanded blastocysts, a shortened equilibration time (8‐11 minutes) is sufficient for effective vitrification.


  • Open Access

    Evaluation of the effect of piezo‐intracytoplasmic sperm injection on the laboratory, clinical, and neonatal outcomes

    by Yoshitaka Fujii, Yuji Endo, Shingo Mitsuhata, Momoko Hayashi, Hiroaki Motoyama

    Purpose: Limited research has been published on the effect of piezo‐assisted intracytoplasmic sperm injection (P‐ICSI). We evaluated the effect of P‐ICSI on the laboratory, clinical, and neonatal outcomes.Methods: This retrospective study was based on the data collected between April 2011 and October 2016. Total 1348 mature oocytes from 145 patients were analyzed. Laboratory, clinical, and neonatal outcomes of those given conventional intracytoplasmic sperm injection (C‐ICSI) and those administered P‐ICSI were examined.Results: P‐ICSI showed significantly more favorable results, with a survival rate of 97.0% (C‐ICSI: 94.1%, P < .010) and a fertilization rate of 83.5% (C‐ICSI: 70.6%, P < .001). There were no differences in the blastocyst development rate, implantation rate, miscarriage rate, live birth rate, gestational age, birth weight, proportion of male neonates, cesarean section rate, and congenital abnormalities between the two patient groups.Conclusions: Our comparison of P‐ICSI with C‐ICSI showed that P‐ICSI significantly improved the survival and fertilization.


  • Open Access

    Effect on clinical and neonatal outcomes of blastocelic microsuction prior to vitrification

    by Shingo Mitsuhata, Yuji Endo, Momoko Hayashi, Yoshitaka Fujii, Hiroaki Motoyama

    Purpose: Microsuction (MS) is a technique for mechanically emptying fluid from blastocele using a microneedle. In this study, we evaluated the improvement in clinical and neonatal outcomes of vitrified blastocyst transfer programs when MS of blastocelic fluid was used before vitrification.Methods: This was a retrospective study based on data collected between March 2014 and August 2016. A total of 317 blastocysts obtained from 211 patients were analyzed. The blastocelic fluid of expanded blastocysts was aspirated completely, and blastocysts were collapsed prior to vitrification. Clinical and neonatal outcomes of warmed blastocysts were compared.Results: The survival rate of the MS blastocyst was significantly higher compared with the nontreatment control (98.7% vs 89.3%, OR: 9.34, 95% CI: 2.35‐36.8, P < 0.01). The rates of implantation and live birth were higher in the MS group than in the control group, but the differences were not significant. There were no differences in gestational age, birthweight, proportion of male babies, rates of cesarean section, and congenital abnormalities.Conclusion: The MS procedure improved blastocyst survival and had little effect on further embryo development after warming.


  • Successful delivery derived from vitrified-warmed spermatozoa from a patient with nonobstructive azoospermia

    by Yuji Endo, Yoshitaka Fujii, Shozo Kurotsuchi, Hiroaki Motoyama, Hiroaki Funahashi


  • Open Access

    Polymorphisms in intron 1 of the EGFR gene in non-small cell lung cancer patients

    by Masayuki Shitara, Hidefumi Sasaki, Keisuke Yokota, Katsuhiro Okuda, Yu Hikosaka, Satoru Moriyama, Motoki Yano, Tomoya Kawaguchi, Akihito Kubo, Minoru Takada, et al.

    The epidermal growth factor receptor (EGFR) gene is highly polymorphic and its expression and activity may be affected by various polymorphisms. There have been several studies examining associations between EGFR polymorphisms and clinical outcome of lung cancer therapy; however, the underlying mechanism is largely unknown. The present study investigated EGFR polymorphism status and its correlation with clinicopathological features in Japanese non-small cell lung cancer (NSCLC) patients. We investigated 5 polymorphisms in the EGFR gene (-216G/T, -191C/A, 8227G/A, D994D and R497K) in 274 surgically-treated NSCLC patients. TaqMan single nucleotide polymorphism (SNP) genotyping assays and a PCR-based assay were used to analyze these polymorphisms. In our cohort of patients we did not find any evidence of the -191C/A polymorphism. Our results showed that the patients with the 8227GA or AA type in intron 1 had a significantly better prognosis with the anti-EGFR therapy than the patients with the GG type (p=0.0448) in terms of recurrence of lung cancer. No significant association was observed between 3 other SNPs (-216G/T, D994D and R497K) and clinicopathological features. The EGFR 8227G/A polymorphism in intron 1 may be associated with clinical outcome in NSCLC patients treated with EGFR tyrosine kinase inhibitors.


  • Simple vitrification for small numbers of human spermatozoa

    by Yuji Endo, Yoshitaka Fujii, Kasumi Shintani, Momoyo Seo, Hiroaki Motoyama, Hiroaki Funahashi


  • Open Access

    ANDROLOGY

    by J. C. Y. Hu, B. K. Seo, Q. V. Neri, Z. Rozenwaks, G. D. Palermo, T. Fields, D. Monahan, Z. Rosenwaks, P. Szkodziak, K. Plewka, et al.

    Introduction: It has been established that only the pool of mature spermatozoa that have completed their maturation process through the transit in the male genital tract sustain the adequate competence. This is to reach the oocyte, penetrate through the cumulus-corona cells, binds to ZP proteins, undergo acrosome reaction, fuse with the oolemma, and finally deliver, at the time of syngamy, an integer paternal genome. It has been proposed that spermatozoa with these properties display on their membrane hyaluronic acid (HA) receptors. Furthermore, the HA selection would identify spermatozoa that are chromosomally normal and that contain an integer DNA capable of supporting embryo development.